Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Curr Diabetes Rev. 2022;18(5):e220321192412. doi: 10.2174/1573399817666210322154618.
Autonomic neuropathy in patients with diabetes mellitus, and especially complications related to gastrointestinal neuropathy, are often overlooked in the clinic. Diabetic gastroenteropathy affects every segment of the gastrointestinal tract and generates symptoms that may include nausea, early satiety, vomiting, abdominal pain, constipation, and diarrhea. Severe cases can be complicated by weight loss, dehydration, and electrolyte disturbances. The pathophysiology is complex, the diagnostics and treatment options are multidisciplinary, and there is generally a lack of evidence for the treatment options. The aims for this review are first to summarize the pathophysiology and describe possible and expected symptoms and complications.Further, we will try to supply the clinician with a straightforward tool for diagnostics, and then, we shall summarize established treatment options, including diet recommendations, pharmacological and non-pharmacological options. Finally, we will explore the multiple possibilities of novel treatment, looking at medications related to the pathophysiology of neuropathy, other manifestations of autonomic neuropathies, and symptomatic treatment for other gastrointestinal disorders, also including new knowledge of endosurgical and neuromodulatory treatment. The overall goal is to increase awareness and knowledge on this frequent diabetic complication and to provide better tools for diagnosis and treatment. Ultimately, we hope to encourage further research in this field, as there are clear shortcomings in terms of biomarkers, pathophysiology, as well as treatment possibilities. In conclusion, diagnosis and management of diabetic gastroenteropathy are challenging and often require multidisciplinary teams and multimodal therapies. Treatment options are sparse, but new pharmacological, endoscopic, and neuromodulatory techniques have shown promising results in initial studies.
糖尿病患者的自主神经病变,尤其是与胃肠道神经病变相关的并发症,在临床上常常被忽视。糖尿病性胃肠病影响胃肠道的每一个节段,产生的症状可能包括恶心、早饱、呕吐、腹痛、便秘和腹泻。严重的病例可能会导致体重减轻、脱水和电解质紊乱。其病理生理学复杂,诊断和治疗选择涉及多学科,并且针对治疗选择通常缺乏证据。本篇综述的目的首先是总结病理生理学,并描述可能出现的症状和并发症。此外,我们将尝试为临床医生提供一种简单的诊断工具,然后总结已确立的治疗选择,包括饮食建议、药理学和非药理学选择。最后,我们将探讨新的治疗方法的多种可能性,包括与神经病变病理生理学相关的药物、其他自主神经病变的表现以及其他胃肠道疾病的对症治疗,还包括内镜和神经调节治疗的新进展。总的来说,提高对这种常见糖尿病并发症的认识和了解,并提供更好的诊断和治疗工具是我们的目标。最终,我们希望鼓励该领域的进一步研究,因为在生物标志物、病理生理学以及治疗可能性方面都存在明显的不足。总之,糖尿病性胃肠病的诊断和管理具有挑战性,通常需要多学科团队和多模式治疗。治疗选择有限,但新的药理学、内镜和神经调节技术在初步研究中显示出了有前景的结果。